Literature DB >> 4614247

A double-blind study of metoclopramide in symptomatic peptic oesophagitis.

C W Venables, D Bell, D Eccleston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4614247

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

Review 1.  A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.

Authors:  N Sharma; C Donnellan; C Preston; B Delaney; G Duckett; P Moayyedi
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 2.  Metoclopramide: a review of its pharmacological properties and clinical use.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 3.  Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 4.  Current approaches in the medical treatment of oesophageal reflux.

Authors:  J E Richter; D O Castell
Journal:  Drugs       Date:  1981-04       Impact factor: 9.546

Review 5.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

Review 6.  Gastroesophageal reflux: clinical presentations, diagnosis and management.

Authors:  W E Waterfall; M A Craven; C J Allen
Journal:  CMAJ       Date:  1986-11-15       Impact factor: 8.262
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.